NASDAQ
Stock News iRobot enters Chapter 11: iRobot (IRBT) filed for Chapter 11 and agreed to be acquired by contract manufacturer Picea Robotics, saying operations and...
China Universal Asset Management Co. Ltd. lifted its position in shares of Kymera Therapeutics, Inc. (NASDAQ: KYMR) by 77.2% in the second quarter, according to the company in its most recent disclosu...
Stock News Tech-led selloff caps tough week: US stocks fell as investors rotated out of mega-cap tech after Broadcom (AVGO) and Oracle (ORCL) stoked AI-spending...
KYMR gains momentum as the FDA grants Fast Track to KT-621 for moderate to severe atopic dermatitis, boosting the stock and advancing its Type 2 pipeline....
Stock News Lululemon leadership change lifts shares: Lululemon Athletica (LULU) said CEO Calvin McDonald will step down Jan. 31, with CFO Meghan Frank and CCO A...
Frontier Capital Management Co. LLC grew its stake in shares of Kymera Therapeutics, Inc. (NASDAQ: KYMR) by 272.7% during the undefined quarter, according to the company in its most recent 13F filing ...
Stock News Oracle sinks, ripples across AI trade: Oracle (ORCL) fell about 11% after a revenue miss and heavier AI capex drove negative free cash flow, pressuri...
WATERTOWN, Mass., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines...
WATERTOWN, Mass. , Dec. 09, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicine...
Kymera jumps after phase Ib study data show KT-621 delivers strong STAT6 degradation and broad clinical activity in patients with atopic dermatitis....
No price data available for this timeframe.